The Optimum Dosage of Prilocaine in Periprostatic Nerve Block During Transrectal Ultrasound Guided Prostate Biopsy: A New Approach in Dose Calculation
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 1
Abstract
Objective: We aimed to calculate the optimum dose of prilocaine per one mL prostate volume in periprostatic nerve block (PPNB) during transrectal ultrasound (TRUS) guided prostate biopsy (PBx). Materials and Methods: We retrospectively evaluated the medical records of 83 patients from whom 12 cores TRUS guided PBx were obtained between years 2011 and 2013. Prostatic sizes were evaluated separately as Size 1 (anterior-posterior on the axial plane), Size 2 (transversal), and Size 3 (cranial-caudal on the sagittal plane) for all patients. The visual analog scores (VAS) of the patients during PBx, prostatic volumes, and prilocaine doses per one mL prostate were evaluated. The correlation between VAS of patients during PBx and prostatic volume, the prostatic sizes and prilocaine dosage per one mL prostate was analyzed using Cubic regression test. Results: It was found that VAS scores of patients were significantly positive correlated with prostatic volume, Size 1, 2 and 3 (p<0.05). However, there was a negative significant correlation between VAS and prilocaine dose per one mL prostate volume (r=-0.402, p<0.01). The dose of 0.1 mL prilocaine infiltration per one mL prostatic tissue in PPNB was the maximum dose that caused a mild and under annoying pain (VAS<2) in patients according to cubic regression formula. Conclusion: Prilocaine dosage, prostatic volume and prostatic sizes (especially anterior-posterior and cranial-caudal) significantly affect VAS scores during TRUS guided PBx. The pain in TRUS guided PBx should be controlled with an optimum dose of prilocaine as 0.1 mL per one mL of prostatic tissue.
Authors and Affiliations
Umut Gönülalan, Murat Koşan, Enis Kervancığlu, Tufan Çiçek, Bülent Öztürk, Hakan Özkardeş
Partial Urethrectomy for Female Urethral Transitional Epithelial Cell Carcinoma
To present a female case of partial urethrectomy and the following adjuvant chemo-radio-therapy for urethral transitional epithelial cell carcinoma originating from distal urethra in the light of literature. The patient...
Does Robot-assisted Surgery in Urology Has Benefits? The Current Status
Minimally invasive surgery has gradually replaced the conventional surgery with the introduction of laparoscopy. Subsequently, with intensive advertisement and marketing strategies, robot-assisted surgery became popular...
Evaluation of General Characteristics of Renal Cell Carcinoma Patients: A Single Center Experience
Objective: Renal cancer (RC) accounts for 3.2% of all newly diagnosed cancers and approximately 90% of RC cases are renal cell carcinoma (RCC). Smoking and hypertension are the most important risk factors. The aim of our...
Incidentally Found Paratesticular Rhabdomyosarcoma: Case Report
Paratesticular rhabdomyosarcomas (RMS) constitute 7% of all RMS. Paratesticular RMS are malignant tumors and although many of them are seen in children and adolescents, 24% of them are seen in adults. A patient in the ol...
Active Surveillance in Prostate Cancer
With the widespread use of the prostate specific antigen and prostate biopsies there has been dramatic increase in the incidence of clinically localized prostate cancer. Although there is no consensus about the treatment...